Methyl trans-3-bromocyclobutane-1-carboxylate, 95, 25g

[(2-FLUOROPYRIDIN-4-YL)METHYL]AMINE HCL, 95.0%, 5g

Methyl 3-amino-5-methoxy-pyridine-2-carboxylate, 98%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5,5,5-trifluoropentanoic acid, 98.0%, 100mg

trimethyl (S)-5-((3-phenoxybenzyl)(1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)benzene-1,2,4-tricarboxylate, 98%, 500mg

alpha-Naphthoflavone>98.0%(HPLC)5g

3,4-Diacetoxybenzaldehyde>98.0%(GC)5g

Hydroxyde de lithium, min 99 %, anhydre, 100 g, emballage plastique.

N~2~-(4-aminophenyl)-N~4~,N~4~,6-trimethylpyrimidine-2,4-diamine, 95.0%, 100mg

(2'-Chloro-biphenyl-3-yl)-acetic acid, 97.0%, 250mg

H-lle-OMe.HCl, 98%, 500g

7-Bromo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine, 95%, 250mg

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 1g